2022-2027 Global and Regional Biosimilars Industry Status and Prospects Professional Market Research Report Standard Version
Date: Jan-2022 | Id: MACRC-74031 | Geographical Scope: Global | Publisher: Mnemonics Research
The global Biosimilars market was valued at 4784.9 Million USD in 2021 and will grow with a CAGR of 18.43% from 2021 to 2027, based on Mnemonics Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). A biosimilar is a biologic medical product highly similar to another already approved biological medicine (the `reference medicine`). Biosimilars are approved according to the same standards of pharmaceutical quality, safety and efficacy that apply to all biological medicines. Biosimilars are officially approved versions of original "innovator" products and can be manufactured when the original product`s patent expires. Reference to the innovator product is an integral component of the approval. By Market Verdors: Pfizer Novartis Biocon Biogen Fresenius Kabi AG Boehringer Ingelheim Merck KgaA Mylan Eli Lilly Teva Pharmaceutical Dr. Reddys Laboratories Amgen Celltrion Samsung Biologics Roche Probiomed Apotex Chong Kun Dang JCR Pharmaceuticals Gan & Lee Pharmaceuticals Gedeon Richter Biocad Coherus Bioscience Stada Arzneimittel AG By Types: Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Recombinant Glycosylated Proteins By Applications: Oncology Blood Disorders Growth Hormonal Deficiency Chronic and Autoimmune Disorders Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview 1.1 Definition 1.2 Assumptions 1.3 Research Scope 1.4 Market Analysis by Regions 1.4.1 North America Market States and Outlook (2022-2027) 1.4.2 East Asia Market States and Outlook (2022-2027) 1.4.3 Europe Market States and Outlook (2022-2027) 1.4.4 South Asia Market States and Outlook (2022-2027) 1.4.5 Southeast Asia Market States and Outlook (2022-2027) 1.4.6 Middle East Market States and Outlook (2022-2027) 1.4.7 Africa Market States and Outlook (2022-2027) 1.4.8 Oceania Market States and Outlook (2022-2027) 1.4.9 South America Market States and Outlook (2022-2027) 1.5 Global Biosimilars Market Size Analysis from 2022 to 2027 1.5.1 Global Biosimilars Market Size Analysis from 2022 to 2027 by Consumption Volume 1.5.2 Global Biosimilars Market Size Analysis from 2022 to 2027 by Value 1.5.3 Global Biosimilars Price Trends Analysis from 2022 to 2027 1.6 COVID-19 Outbreak: Biosimilars Industry Impact Chapter 2 Global Biosimilars Competition by Types, Applications, and Top Regions and Countries 2.1 Global Biosimilars (Volume and Value) by Type 2.1.1 Global Biosimilars Consumption and Market Share by Type (2016-2021) 2.1.2 Global Biosimilars Revenue and Market Share by Type (2016-2021) 2.2 Global Biosimilars (Volume and Value) by Application 2.2.1 Global Biosimilars Consumption and Market Share by Application (2016-2021) 2.2.2 Global Biosimilars Revenue and Market Share by Application (2016-2021) 2.3 Global Biosimilars (Volume and Value) by Regions 2.3.1 Global Biosimilars Consumption and Market Share by Regions (2016-2021) 2.3.2 Global Biosimilars Revenue and Market Share by Regions (2016-2021) Chapter 3 Production Market Analysis 3.1 Global Production Market Analysis 3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis 3.1.2 2016-2021 Major Manufacturers Performance and Market Share 3.2 Regional Production Market Analysis 3.2.1 2016-2021 Regional Market Performance and Market Share 3.2.2 North America Market 3.2.3 East Asia Market 3.2.4 Europe Market 3.2.5 South Asia Market 3.2.6 Southeast Asia Market 3.2.7 Middle East Market 3.2.8 Africa Market 3.2.9 Oceania Market 3.2.10 South America Market 3.2.11 Rest of the World Market Chapter 4 Global Biosimilars Sales, Consumption, Export, Import by Regions (2016-2021) 4.1 Global Biosimilars Consumption by Regions (2016-2021) 4.2 North America Biosimilars Sales, Consumption, Export, Import (2016-2021) 4.3 East Asia Biosimilars Sales, Consumption, Export, Import (2016-2021) 4.4 Europe Biosimilars Sales, Consumption, Export, Import (2016-2021) 4.5 South Asia Biosimilars Sales, Consumption, Export, Import (2016-2021) 4.6 Southeast Asia Biosimilars Sales, Consumption, Export, Import (2016-2021) 4.7 Middle East Biosimilars Sales, Consumption, Export, Import (2016-2021) 4.8 Africa Biosimilars Sales, Consumption, Export, Import (2016-2021) 4.9 Oceania Biosimilars Sales, Consumption, Export, Import (2016-2021) 4.10 South America Biosimilars Sales, Consumption, Export, Import (2016-2021) Chapter 5 North America Biosimilars Market Analysis 5.1 North America Biosimilars Consumption and Value Analysis 5.1.1 North America Biosimilars Market Under COVID-19 5.2 North America Biosimilars Consumption Volume by Types 5.3 North America Biosimilars Consumption Structure by Application 5.4 North America Biosimilars Consumption by Top Countries 5.4.1 United States Biosimilars Consumption Volume from 2016 to 2021 5.4.2 Canada Biosimilars Consumption Volume from 2016 to 2021 5.4.3 Mexico Biosimilars Consumption Volume from 2016 to 2021 Chapter 6 East Asia Biosimilars Market Analysis 6.1 East Asia Biosimilars Consumption and Value Analysis 6.1.1 East Asia Biosimilars Market Under COVID-19 6.2 East Asia Biosimilars Consumption Volume by Types 6.3 East Asia Biosimilars Consumption Structure by Application 6.4 East Asia Biosimilars Consumption by Top Countries 6.4.1 China Biosimilars Consumption Volume from 2016 to 2021 6.4.2 Japan Biosimilars Consumption Volume from 2016 to 2021 6.4.3 South Korea Biosimilars Consumption Volume from 2016 to 2021 Chapter 7 Europe Biosimilars Market Analysis 7.1 Europe Biosimilars Consumption and Value Analysis 7.1.1 Europe Biosimilars Market Under COVID-19 7.2 Europe Biosimilars Consumption Volume by Types 7.3 Europe Biosimilars Consumption Structure by Application 7.4 Europe Biosimilars Consumption by Top Countries 7.4.1 Germany Biosimilars Consumption Volume from 2016 to 2021 7.4.2 UK Biosimilars Consumption Volume from 2016 to 2021 7.4.3 France Biosimilars Consumption Volume from 2016 to 2021 7.4.4 Italy Biosimilars Consumption Volume from 2016 to 2021 7.4.5 Russia Biosimilars Consumption Volume from 2016 to 2021 7.4.6 Spain Biosimilars Consumption Volume from 2016 to 2021 7.4.7 Netherlands Biosimilars Consumption Volume from 2016 to 2021 7.4.8 Switzerland Biosimilars Consumption Volume from 2016 to 2021 7.4.9 Poland Biosimilars Consumption Volume from 2016 to 2021 Chapter 8 South Asia Biosimilars Market Analysis 8.1 South Asia Biosimilars Consumption and Value Analysis 8.1.1 South Asia Biosimilars Market Under COVID-19 8.2 South Asia Biosimilars Consumption Volume by Types 8.3 South Asia Biosimilars Consumption Structure by Application 8.4 South Asia Biosimilars Consumption by Top Countries 8.4.1 India Biosimilars Consumption Volume from 2016 to 2021 8.4.2 Pakistan Biosimilars Consumption Volume from 2016 to 2021 8.4.3 Bangladesh Biosimilars Consumption Volume from 2016 to 2021 Chapter 9 Southeast Asia Biosimilars Market Analysis 9.1 Southeast Asia Biosimilars Consumption and Value Analysis 9.1.1 Southeast Asia Biosimilars Market Under COVID-19 9.2 Southeast Asia Biosimilars Consumption Volume by Types 9.3 Southeast Asia Biosimilars Consumption Structure by Application 9.4 Southeast Asia Biosimilars Consumption by Top Countries 9.4.1 Indonesia Biosimilars Consumption Volume from 2016 to 2021 9.4.2 Thailand Biosimilars Consumption Volume from 2016 to 2021 9.4.3 Singapore Biosimilars Consumption Volume from 2016 to 2021 9.4.4 Malaysia Biosimilars Consumption Volume from 2016 to 2021 9.4.5 Philippines Biosimilars Consumption Volume from 2016 to 2021 9.4.6 Vietnam Biosimilars Consumption Volume from 2016 to 2021 9.4.7 Myanmar Biosimilars Consumption Volume from 2016 to 2021 Chapter 10 Middle East Biosimilars Market Analysis 10.1 Middle East Biosimilars Consumption and Value Analysis 10.1.1 Middle East Biosimilars Market Under COVID-19 10.2 Middle East Biosimilars Consumption Volume by Types 10.3 Middle East Biosimilars Consumption Structure by Application 10.4 Middle East Biosimilars Consumption by Top Countries 10.4.1 Turkey Biosimilars Consumption Volume from 2016 to 2021 10.4.2 Saudi Arabia Biosimilars Consumption Volume from 2016 to 2021 10.4.3 Iran Biosimilars Consumption Volume from 2016 to 2021 10.4.4 United Arab Emirates Biosimilars Consumption Volume from 2016 to 2021 10.4.5 Israel Biosimilars Consumption Volume from 2016 to 2021 10.4.6 Iraq Biosimilars Consumption Volume from 2016 to 2021 10.4.7 Qatar Biosimilars Consumption Volume from 2016 to 2021 10.4.8 Kuwait Biosimilars Consumption Volume from 2016 to 2021 10.4.9 Oman Biosimilars Consumption Volume from 2016 to 2021 Chapter 11 Africa Biosimilars Market Analysis 11.1 Africa Biosimilars Consumption and Value Analysis 11.1.1 Africa Biosimilars Market Under COVID-19 11.2 Africa Biosimilars Consumption Volume by Types 11.3 Africa Biosimilars Consumption Structure by Application 11.4 Africa Biosimilars Consumption by Top Countries 11.4.1 Nigeria Biosimilars Consumption Volume from 2016 to 2021 11.4.2 South Africa Biosimilars Consumption Volume from 2016 to 2021 11.4.3 Egypt Biosimilars Consumption Volume from 2016 to 2021 11.4.4 Algeria Biosimilars Consumption Volume from 2016 to 2021 11.4.5 Morocco Biosimilars Consumption Volume from 2016 to 2021 Chapter 12 Oceania Biosimilars Market Analysis 12.1 Oceania Biosimilars Consumption and Value Analysis 12.2 Oceania Biosimilars Consumption Volume by Types 12.3 Oceania Biosimilars Consumption Structure by Application 12.4 Oceania Biosimilars Consumption by Top Countries 12.4.1 Australia Biosimilars Consumption Volume from 2016 to 2021 12.4.2 New Zealand Biosimilars Consumption Volume from 2016 to 2021 Chapter 13 South America Biosimilars Market Analysis 13.1 South America Biosimilars Consumption and Value Analysis 13.1.1 South America Biosimilars Market Under COVID-19 13.2 South America Biosimilars Consumption Volume by Types 13.3 South America Biosimilars Consumption Structure by Application 13.4 South America Biosimilars Consumption Volume by Major Countries 13.4.1 Brazil Biosimilars Consumption Volume from 2016 to 2021 13.4.2 Argentina Biosimilars Consumption Volume from 2016 to 2021 13.4.3 Columbia Biosimilars Consumption Volume from 2016 to 2021 13.4.4 Chile Biosimilars Consumption Volume from 2016 to 2021 13.4.5 Venezuela Biosimilars Consumption Volume from 2016 to 2021 13.4.6 Peru Biosimilars Consumption Volume from 2016 to 2021 13.4.7 Puerto Rico Biosimilars Consumption Volume from 2016 to 2021 13.4.8 Ecuador Biosimilars Consumption Volume from 2016 to 2021 Chapter 14 Company Profiles and Key Figures in Biosimilars Business 14.1 Pfizer 14.1.1 Pfizer Company Profile 14.1.2 Pfizer Biosimilars Product Specification 14.1.3 Pfizer Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.2 Novartis 14.2.1 Novartis Company Profile 14.2.2 Novartis Biosimilars Product Specification 14.2.3 Novartis Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.3 Biocon 14.3.1 Biocon Company Profile 14.3.2 Biocon Biosimilars Product Specification 14.3.3 Biocon Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.4 Biogen 14.4.1 Biogen Company Profile 14.4.2 Biogen Biosimilars Product Specification 14.4.3 Biogen Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.5 Fresenius Kabi AG 14.5.1 Fresenius Kabi AG Company Profile 14.5.2 Fresenius Kabi AG Biosimilars Product Specification 14.5.3 Fresenius Kabi AG Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.6 Boehringer Ingelheim 14.6.1 Boehringer Ingelheim Company Profile 14.6.2 Boehringer Ingelheim Biosimilars Product Specification 14.6.3 Boehringer Ingelheim Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.7 Merck KgaA 14.7.1 Merck KgaA Company Profile 14.7.2 Merck KgaA Biosimilars Product Specification 14.7.3 Merck KgaA Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.8 Mylan 14.8.1 Mylan Company Profile 14.8.2 Mylan Biosimilars Product Specification 14.8.3 Mylan Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.9 Eli Lilly 14.9.1 Eli Lilly Company Profile 14.9.2 Eli Lilly Biosimilars Product Specification 14.9.3 Eli Lilly Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.10 Teva Pharmaceutical 14.10.1 Teva Pharmaceutical Company Profile 14.10.2 Teva Pharmaceutical Biosimilars Product Specification 14.10.3 Teva Pharmaceutical Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.11 Dr. Reddys Laboratories 14.11.1 Dr. Reddys Laboratories Company Profile 14.11.2 Dr. Reddys Laboratories Biosimilars Product Specification 14.11.3 Dr. Reddys Laboratories Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.12 Amgen 14.12.1 Amgen Company Profile 14.12.2 Amgen Biosimilars Product Specification 14.12.3 Amgen Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.13 Celltrion 14.13.1 Celltrion Company Profile 14.13.2 Celltrion Biosimilars Product Specification 14.13.3 Celltrion Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.14 Samsung Biologics 14.14.1 Samsung Biologics Company Profile 14.14.2 Samsung Biologics Biosimilars Product Specification 14.14.3 Samsung Biologics Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.15 Roche 14.15.1 Roche Company Profile 14.15.2 Roche Biosimilars Product Specification 14.15.3 Roche Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.16 Probiomed 14.16.1 Probiomed Company Profile 14.16.2 Probiomed Biosimilars Product Specification 14.16.3 Probiomed Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.17 Apotex 14.17.1 Apotex Company Profile 14.17.2 Apotex Biosimilars Product Specification 14.17.3 Apotex Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.18 Chong Kun Dang 14.18.1 Chong Kun Dang Company Profile 14.18.2 Chong Kun Dang Biosimilars Product Specification 14.18.3 Chong Kun Dang Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.19 JCR Pharmaceuticals 14.19.1 JCR Pharmaceuticals Company Profile 14.19.2 JCR Pharmaceuticals Biosimilars Product Specification 14.19.3 JCR Pharmaceuticals Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.20 Gan & Lee Pharmaceuticals 14.20.1 Gan & Lee Pharmaceuticals Company Profile 14.20.2 Gan & Lee Pharmaceuticals Biosimilars Product Specification 14.20.3 Gan & Lee Pharmaceuticals Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.21 Gedeon Richter 14.21.1 Gedeon Richter Company Profile 14.21.2 Gedeon Richter Biosimilars Product Specification 14.21.3 Gedeon Richter Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.22 Biocad 14.22.1 Biocad Company Profile 14.22.2 Biocad Biosimilars Product Specification 14.22.3 Biocad Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.23 Coherus Bioscience 14.23.1 Coherus Bioscience Company Profile 14.23.2 Coherus Bioscience Biosimilars Product Specification 14.23.3 Coherus Bioscience Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.24 Stada Arzneimittel AG 14.24.1 Stada Arzneimittel AG Company Profile 14.24.2 Stada Arzneimittel AG Biosimilars Product Specification 14.24.3 Stada Arzneimittel AG Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021) Chapter 15 Global Biosimilars Market Forecast (2022-2027) 15.1 Global Biosimilars Consumption Volume, Revenue and Price Forecast (2022-2027) 15.1.1 Global Biosimilars Consumption Volume and Growth Rate Forecast (2022-2027) 15.1.2 Global Biosimilars Value and Growth Rate Forecast (2022-2027) 15.2 Global Biosimilars Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027) 15.2.1 Global Biosimilars Consumption Volume and Growth Rate Forecast by Regions (2022-2027) 15.2.2 Global Biosimilars Value and Growth Rate Forecast by Regions (2022-2027) 15.2.3 North America Biosimilars Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.4 East Asia Biosimilars Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.5 Europe Biosimilars Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.6 South Asia Biosimilars Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.7 Southeast Asia Biosimilars Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.8 Middle East Biosimilars Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.9 Africa Biosimilars Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.10 Oceania Biosimilars Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.11 South America Biosimilars Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.3 Global Biosimilars Consumption Volume, Revenue and Price Forecast by Type (2022-2027) 15.3.1 Global Biosimilars Consumption Forecast by Type (2022-2027) 15.3.2 Global Biosimilars Revenue Forecast by Type (2022-2027) 15.3.3 Global Biosimilars Price Forecast by Type (2022-2027) 15.4 Global Biosimilars Consumption Volume Forecast by Application (2022-2027) 15.5 Biosimilars Market Forecast Under COVID-19 Chapter 16 Conclusions Research Methodology
Related reports
Non-Hodgkin Lymphoma Therapeutics Market
$2000-$6000
Acrylic Teeth Market
$3600-$7000